OpenAI and Molecule.one demonstrate near-autonomous AI chemist using GPT-5.4 to improve drug-making reaction

Jul 10, 2026

OpenAI and Molecule.one have demonstrated a near-autonomous AI chemist that uses GPT-5.4 to improve a challenging reaction in medicinal chemistry. The system advances automated drug discovery by optimizing a key synthesis step.

Why it matters: This work shows how AI can autonomously improve complex chemical reactions, potentially accelerating drug development and reducing manual lab work.

Full story at: OpenAI News ↗